Will the Presidential Health Summit be a turning point? The pill the sick and ailing health system needs? Only time will tell, but yesterday the report with the outputs from the October summit was released in Cape Town. Read the report and the President’s speech here.
South Africa has been “on the brink” of major health system change for almost a decade. National Health Insurance (NHI) has been the buzz-phrase for years, but somehow it is still one of the most elusive policies of our time and it is made less tangible with each iteration of the policy. Sasha Stevenson and Nomatter Ndebele on why we are nowhere.
Tonight when President Cyril Ramaphosa delivers his second state of the nation address (SONA) he will say very little about the actual health of the nation. Mark Heywood unpacks what the President is unlikely to address in his SONA tonight and why that is poor
All nine of South Africa’s provinces have finalised their NSP provincial implementation plans and six out of nine provincial AIDS councils are chaired by premiers, according to the South African National AIDS Council.
South Africa urgently needs a pregnancy register to help establish whether an important new antiretroviral medicine causes birth abnormalities, argues Tom Boyles.
Nearly a year on from the crippling health sector strikes in the North West province the full cost is still to emerge. UFRIEDA HO reflects that even the “victors” lost.
While the advantages of the new antiretroviral drug dolutegravir have been extensively reported, the potential disadvantages have received relatively little attention, says Dr Tom Boyles.
An independent commissioned following multiple allegations of sexual harassment and bullying by senior staff at UNAIDS has been released telling a story of patriarchy, harassment and abuse of authority. At…
In February 2018 the Medicines Control Council was replaced by the South African Health Products Regulatory Authority. Spotlight sent SAHPRA 12 questions to gauge how things are going with the new regulator.
On World AIDS Day 2018 we assess how South Africa is faring against 10 key targets set in the National Strategic Plan (NSP) on HIV, TB and STIs 2017 – 2022.
Dolutegravir is a critically important antiretroviral medicine that is set to become the backbone of South Africa and many other countries’ HIV programmes.
An important new antiretroviral medicine will soon become available to people living with HIV in various Sub-Saharan African countries. Unfortunately, many women might be denied access to this new drug due to an inability of regulators and health departments to see potential risks associated with the drug in the proper context.